FDA Shrinks Scope of Convalescent Plasma For COVID-19

(MedPage Today) -- The FDA limited the scope of authorized COVID-19 convalescent plasma use to a subset of hospitalized patients, in a revision issued on Thursday.
According to the updated emergency use authorization (EUA), only high-titer convalescent...